High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
Three-fourths of patients had clear margins after surgery
Revolutionary’ move in curing cancer on the horizon
A biotech company’s CEO discusses upcoming revolutionary approaches in cancer treatment, highlighting the role of new technologies.
FDA Approves Amgen Treatment For Pretreated Colorectal Cancer With Certain Mutation – Amgen (NASDAQ:AMGN) – Benzinga
Amgen’s Lumakras treatment, combined with Vectibix, is FDA-approved for KRAS G12C-mutated colorectal cancer.
Merck and Eisai announce positive Phase 3 results for Keytruda and Lenvima combination
The combination of Keytruda and Lenvima met primary endpoints in a Phase 3 trial, showing significant improvement in overall survival for patients with advanced cancers.
KU, Children’s Mercy, Saint Luke’s focus on precision medicine – Kansas City Business Journal
Using a patient’s genomics to craft a treatment plan shows great promise for cancer and rare disease patients, and these three KC-area providers are dialing up their offerings.
Press release for research from the 2024 ASTRO Annual Meeting
IMRT and proton therapy offer equally high quality of life and tumor control for people with prostate cancer – American Society for Radiation Oncology (ASTRO)
Bayers posts Phase 3 win for hot flashes drug (BAYRY:) (BAYRY) | Seeking Alpha
Bayer (BAYZF) (BAYRY) says elinzanetant, its experimental therapy for hot flashes, reached the main goals in a late-stage trial. Read more here.
Toxic glass kills 99% of bone cancer without harming healthy cells
Scientists have demonstrated a new potential treatment for bone cancer. A bioactive glass laced with a toxic metal was able to kill up to 99% of the cancer without harming healthy cells, and could even help regrow healthy bone after.
Swedish researchers discuss advancements, promise of new radiotherapy techniques
Radiotherapy is a cornerstone of cancer care. However, in recent decades, Sweden has fallen behind in this area, both in terms of health care resources and research. Medicinsk Vetenskap has interviewed researchers who want to continue developing a bright idea.
Cancer breakthrough finally maps how deadly tumors spread through the body
Scientists have created a revolutionary method to track the spread of cancer throughout the body, potentially paving the way for more effective treatments.
A new weapon in the battle against cancer: The story of combo prodrug TTFA-Platin
Cancer is a deadly disease taking the lives of thousands of people worldwide, and researchers are constantly looking for better alternatives for treatment. One of the major breakthroughs is combination therapy—a treatment modality that uses two or more drugs for the treatment of cancer more effectively.
"100% successful" cancer drug gets landmark FDA approval
Hugely promising cancer drug dostarlimab is one step closer to being widely available, after the Food and Drug Administration granted it Breakthrough Therapy Designation status that, if successful, will expedite its path to market.
